Octogenarians undergoing pancreaticoduodenectomy: Assessing outcomes, disposition, and timing of chemotherapy.

Table 3 shows that there was a trend toward fewer octogenarians with pancreatic cancer receiving chemotherapy in either the neoadjuvant or adjuvant setting compared to their younger counterparts, although this did not reach statistical significance (50% vs 68%, P = .08).

also in 111,027 other papers